Key Market Indicator:
F&G: 21
24.775,30 NASDAQ · 46.455,00 DOW · 6.659,05 S&P · 4.013,68 Gold · 63,55 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© BusinessWire
02.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages LifeMD, Inc. (LFMD) Investors To Inquire About Securities Fraud Class Action
Article
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”)....
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US6556631025
Nordson Corp
NDSN
LISTED
NASDAQ
Quasar Medical Strengthens Global CDMO Platform with Acquisition of Nordson Medical's Galway and Tecate Facilities
Article
News Preview
This milestone enhances Quasar's global CDMO platform, broadening end-to-end capabilities and providing increased value for medical device OEMs and innovators. GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Quasar Medical, a global leader in manufacturing interventional and minimally invasive medical devices, today announced the completion of its...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: US6294441000
NRx Pharmaceuticals, Inc.
NRXP
LISTED
NASDAQ
UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office
Article
News Preview
SOUTHAMPTON, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP), a clinical-stage biopharmaceutical company, presented two keynote talks to a gathering of leading family offices and family members sponsored by the Global Passion Project and the Rockefeller Global Family Office on August 28-30, 2025 in Southampton, NY...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
02.09.2025
ISIN: US6556631025
Nordson Corp
NDSN
LISTED
NASDAQ
Quasar Medical Strengthens Global CDMO Platform with Acquisition of Nordson Medical's Galway and Tecate Facilities
Article
News Preview
This milestone enhances Quasar's global CDMO platform, broadening end-to-end capabilities and providing increased value for medical device OEMs and innovators. GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Quasar Medical, a global leader in manufacturing interventional and minimally invasive medical devices, today announced the completion of its...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
02.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
CNC Investors Have Opportunity to Join Centene Corporation Fraud Investigation with the Schall Law Firm
Article
News Preview
LOS ANGELES, Sept. 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of the securities laws....
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Lead Plaintiff Deadline on September 8, 2025 for CNC Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm
Article
News Preview
RADNOR, Pa., Sept. 2, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Centene Corporation ("Centene") (NYSE: CNC) on behalf of those who purchased or otherwise acquired Centene securities between December 12, 2024, and June...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Class Action Reminder for REPL Investors: Kessler Topaz Meltzer & Check, LLP Reminds Replimune Group, Inc. (REPL) Investors of Securities Fraud Class Action Lawsuit
Article
News Preview
RADNOR, Pa., Sept. 2, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Replimune Group, Inc. ("Replimune") (NASDAQ: REPL) on behalf of those who purchased or otherwise acquired Replimune securities between November 22, 2024, a...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
Article
News Preview
Informations relatives au nombre total de droits de vote et d’actions composant le capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 35 - 2025
Article
News Preview
Aggregated presentation by day and by market Statement of transactions in own shares from August 25th to August 29th 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Appoints Jordy Winters as Vice President of OUS Sales to Accelerate International Growth
Article
News Preview
TAMPERE, Finland, Sept. 2, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today the appointment of Jordy Winters as Vice President of Sales Outside U.S. (OUS; Europe and Rest of the World) and member of the Management Team. Winters will spearhead Bioretec's international commercial strategy, advancing th...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Appoints Jordy Winters as Vice President of OUS Sales to Accelerate International Growth
Article
News Preview
TAMPERE, Finland, Sept. 2, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today the appointment of Jordy Winters as Vice President of Sales Outside U.S. (OUS; Europe and Rest of the World) and member of the Management Team. Winters will spearhead Bioretec's international commercial strategy, advancing th...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US15117F8804
Cellectar Biosciences, Inc.
CLRB
LISTED
NASDAQ
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands
Article
News Preview
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Sept. 2, 2025 /CNW/ -- Cancer innovation is reaching new heights as the FDA approved breakthrough therapies for aggressive malignancies, including Modeyso for deadly brain tumors, while breakthrough designations accelerate for next-generation therapies targe...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
02.09.2025
ISIN: US15117F8804
Cellectar Biosciences, Inc.
CLRB
LISTED
NASDAQ
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands
Article
News Preview
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Sept. 2, 2025 /PRNewswire/ -- Cancer innovation is reaching new heights as the FDA approved breakthrough therapies for aggressive malignancies, including Modeyso for deadly brain tumors, while breakthrough designations accelerate for next-generation therapie...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US15117F8804
Cellectar Biosciences, Inc.
CLRB
LISTED
NASDAQ
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands
Article
News Preview
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Sept. 2, 2025 /PRNewswire/ -- Cancer innovation is reaching new heights as the FDA approved breakthrough therapies for aggressive malignancies, including Modeyso for deadly brain tumors, while breakthrough designations accelerate for next-generation therapie...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US71715X2036
PharmaCyte Biotech, Inc.
PMCB
LISTED
NASDAQ
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
Article
News Preview
PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced that it has increased its stake in TNF Pharmaceuticals (Nasdaq: TNFA, “TNF”) by an additional $3 million. The Company does so to help support TNF’s recent acquisition of a license with LightSolver, Ltd. (“LightSolver”), a company recognized by Gartner and the W...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US62856X3008
Q/C Technologies, Inc
QCLS
LISTED
NASDAQ
TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications
Article
News Preview
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”) today announced that it has entered into a licensing agreement for an innovative processing accelerator designed to expedite compute-intensive computations In partnership with LightSolver Ltd. (“LightSolver”), a company recognized by Gartner and the World Economic Forum for its brea...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: CNE100003N76
Shanghai Henlius Biotech, Inc.
2696
LISTED
HKSE
US Food and Drug Administration (FDA) Approves Henlius and Organon's BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively
Article
News Preview
SHANGHAI and JERSEY CITY, N.J., Sept. 2, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) has approved BILDYOS® (denosumab-nxxp) injection 60 mg/mL and BILPREVDA® (denosumab-nxxp) injection 120 mg/1.7 mL, biosimilars to PROLIA (denosumab) and XGEVA (de...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US0311621009
Amgen Inc
AMGN
LISTED
NASDAQ
AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS
Article
News Preview
Research and Development Infrastructure Investment Expected to Create Hundreds of U.S. Jobs  THOUSAND OAKS, Calif., Sept. 2, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The cent...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: KR7096530001
Seegene Inc
096530
LISTED
KOE
Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants
Article
News Preview
-        The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026-        Selected researchers will receive up to USD 600,000 in research funding, along with access to Seegene's syndromic PCR assays, instruments, and software-       ...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: KR7096530001
Seegene Inc
096530
LISTED
KOE
Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants
Article
News Preview
-        The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026-        Selected researchers will receive up to USD 600,000 in research funding, along with access to Seegene's syndromic PCR assays, instruments, and software-       ...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: KR7096530001
Seegene Inc
096530
LISTED
KOE
Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants
Article
News Preview
-        The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026-        Selected researchers will receive up to USD 600,000 in research funding, along with access to Seegene's syndromic PCR assays, instruments, and software-       ...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: KR7096530001
Seegene Inc
096530
LISTED
KOE
Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants
Article
News Preview
-        The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026-        Selected researchers will receive up to USD 600,000 in research funding, along with access to Seegene's syndromic PCR assays, instruments, and software-       ...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: KR7328130000
Lunit Inc.
328130
LISTED
KOE
Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program
Article
News Preview
Milestone European deployment underscores growing global trust in Lunit's AI for population-wide breast cancer screening SEOUL, South Korea, Sept. 2, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that its solutions have been selected as the exclusive AI tools for the...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US38246G1085
GoodRx Holdings, Inc.
GDRX
LISTED
NASDAQ
GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing
Article
News Preview
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., is riding into new creative territory with the launch of The Savings Wrangler, a groundbreaking brand campaign that aims to bring the company’s mission to life in an unforgettable way. Designed to deepen cultural relevance and brand resonance, the campaign introduces a...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Announces New U.S. Health Claims Data Analysis Finds Over 50% Increase in the Estimated Number of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) Patients Compared to Previous Claims Analysis
Article
News Preview
Savara Inc. (the “Company”) (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced an increased estimate of autoimmune PAP diagnosed prevalence in the U.S. The updated analysis indicates an ~50% larger autoimmune PAP patient population in the U.S. than the Company’s previously estimated cla...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US46266C1053
IQVIA Holdings Inc
IQV
LISTED
NYSE
IQVIA Announces CFO Transition in Early 2026
Article
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences and healthcare industries, today announced a planned leadership transition in its finance organization. Michael Fedock, currently Senior Vice President of Financial Planning & Anal...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US03528H1095
Anixa Biosciences, Inc.
ANIX
LISTED
NASDAQ
Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
Article
News Preview
SAN JOSE, Calif., Sept. 2, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the time of management's presentation at the H.C. Wainwright 27th Annual Global Investment Conference, being held September 8th – 10th, 2...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
Article
News Preview
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: clearance of the SmartGuard™ algorithm as an interoperable automated glycemic controller (iAGC), enab...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Centene Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 8, 2025 to Discuss Your Rights - CNC
Article
News Preview
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recov...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Levi & Korsinsky Notifies Replimune Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - REPL
Article
News Preview
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ: REPL) of a class action securities lawsuit. CLASS DEFINITION: The law...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
Shareholders that lost money on RxSight, Inc.(RXST) should contact Levi & Korsinsky about pending Class Action - RXST
Article
News Preview
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to re...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Levi & Korsinsky Notifies Biohaven Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - BHVN
Article
News Preview
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ("Biohaven Ltd." or the "Company") (NYSE: BHVN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to reco...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Levi & Korsinsky Notifies Shareholders of Alto Neuroscience, Inc.(ANRO) of a Class Action Lawsuit and an Upcoming Deadline
Article
News Preview
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Alto Neuroscience, Inc. ("Alto Neuroscience, Inc." or the "Company") (NYSE: ANRO) of a class action securities lawsuit. CLASS DEFINITION: The l...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Class Action Filed Against Neogen Corporation (NEOG) Seeking Recovery for Investors - Contact Levi & Korsinsky
Article
News Preview
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Neogen Corporation ("Neogen Corporation" or the "Company") (NASDAQ: NEOG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit s...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: IL0011595993
InMode Ltd.
INMD
LISTED
NASDAQ
InMode to Present at Baird 2025 Global Healthcare Conference
Article
News Preview
YOKNEAM, Israel, Sept. 2, 2025 /PRNewswire/ --  InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will present in-person at the Baird 2025 Global Healthcare Conference in New York on Sept. 10, 2025. The fireside chat, moderated by Jeff Johnson, Senio...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US3724462037
Genprex Inc
GNPX
LISTED
NASDAQ
Genprex to Present and Participate at Upcoming September Investor and Industry Conferences
Article
News Preview
Presentation to Highlight the Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas, Sept. 2, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the Company's participatio...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US29405E2081
Enveric Biosciences, Inc.
ENVB
LISTED
NASDAQ
Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA
Article
News Preview
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced the relocation of its corporate headquarters to Cambridge, Massachusetts, 02142. Enveric believes the move will foster stronger coll...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: CA25253X2077
DiaMedica Therapeutics, Inc.
DMAC
LISTED
NASDAQ
DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference
Article
News Preview
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that Rick Pauls, President and CEO, and Dave Wambeke, Chief Business Officer, will participate in a fireside chat at the upcoming Cantor...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Article
News Preview
LOS ANGELES, Sept. 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RxSight, Inc. ("RxSight" or "the Company") (NASDAQ: RXST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Se...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US44148G2049
Hoth Therapeutics, Inc.
HOTH
LISTED
NASDAQ
Hoth Therapeutics' Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards
Article
News Preview
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced combined positive findings from multiple preclinical programs evaluating its precision antisense candidate HT-KIT, including compelling anti-tumor efficacy, a clean safety profile, and new GLP-validated bio...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site
Article
News Preview
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the completion of its acquisition of Sanofi’s state-of-the-art sterile fill-finish and packaging site in Ridgefield, New Jersey, marking an expansion of the companies’ strategic partnership to enable additional U.S. drug product manufacturing. The terms...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: CA45257F2008
ImmunoPrecise Antibodies Ltd.
IPA
LISTED
NASDAQ
ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New York
Article
News Preview
ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), today announced that it will participate in the 27th Annual H.C. Wainwright Global Investment Conference, taking place September 8th through September 10th, 2025. Dr. Jennifer Bath, President CEO of IPA, will deliver a company presentation and be available for one-on-one inves...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson Unveils Results from the VARIPURE Substudy of SECURE, a Real-World Study on VARIPULSE™ Platform, at 2025 European Society of Cardiology (ESC) Congress
Article
News Preview
VARIPURE demonstrated strong safety outcomes with no incidence of stroke and 99.7% acute effectiveness of the VARIPULSE™ Platform in nearly 800 enrolled patientsi IRVINE, Calif., Sept. 2, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) -- Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced ac...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.
Article
News Preview
Accelerates Solventum's business transformation to deliver long-term shareholder valueNet proceeds will be used primarily to pay down debtST. PAUL, Minn., Sept. 2, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today announced it has completed the sale of its Purification & Filtration business ("P&F") to Thermo Fisher Scientific Inc. (NYSE:...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US50015M1099
Kodiak Sciences Inc
KOD
LISTED
NASDAQ
Kodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI)
Article
News Preview
PALO ALTO, Calif., Sept. 2, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced participation in two upcoming scientific meetings:  The 25th EURetina Congress and The Retina Society 58th A...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US68236V3024
ETHZilla Corporation
ETHZ
LISTED
NASDAQ
ETHZilla Plans to Deploy $100 Million in ETH to EtherFi for Restaking Initiatives
Article
News Preview
Partnership marks ETHZilla's first engagement with DeFi protocols Company has accumulated 102,246 ETH at an average acquisition price of $3,948.72, valued at approximately $456 million PALM BEACH, Fla., Sept. 2, 2025 /PRNewswire/ -- ETHZilla Corporation (Nasdaq: ETHZ), (the "Company" or "ETHZilla"), today announced its plans to deploy into the de...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US00032Q1040
Whitehawk Therapeutics Inc
AADI
LISTED
NASDAQ
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
Article
News Preview
MORRISTOWN, N.J., Sept. 2, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, announced today that the Company's president and CEO, Dave Lennon, PhD, will participate in a fireside chat...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: DE0005313704
Carl Zeiss Meditec AG
AFX
LISTED
XETR
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones
Article
News Preview
ZEISS Medical Technology will showcase new ophthalmic innovations and market milestones at ESCRS from Sept. 12 - 15 in Copenhagen, Denmark: EFFICIENT, CONFIDENT DECISION MAKING: introducing AI-powered CIRRUS® PathFinder™ clinical support tool now CE mark approved; presenting a fully integrated diagnostic and SLT therapeutic solution for managing...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Article
News Preview
NORTH CHICAGO, Ill., Sept. 2, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025. Management will participate in a fireside chat at 9:00 a.m. Central time. A live audio webcast of the presentation will be accessible through AbbVie's Investor Relati...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US1011371077
Boston Scientific Corp
BSX
LISTED
NYSE
Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results
Article
News Preview
MARLBOROUGH, Mass., Sept. 2, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host a meeting with the investor community to review its financial goals and long-term growth strategies on Tuesday, September 30, 2025, beginning at 8:30 a.m. ET....
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US00846U1016
Agilent Technologies Inc
A
LISTED
NYSE
Agilent’s MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer
Article
News Preview
Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification under EU in vitro diagnostic regulation (IVDR)1 as a CDx test for colorectal cancer. MMR IHC Panel pharmDx (Dako Omnis) is indicated as an aid to identify mismatch repair (MMR) deficient CRC...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US90184D1000
Twist Bioscience Corp
TWST
LISTED
NASDAQ
Twist Bioscience Collaborates with Synthetic Design Lab
Article
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has collaborated with next generation therapeutics company, Synthetic Design Lab (SDL). “With our high throughput expertise, from novel binder discovery services to high throughput screening capabilities, we’re able to support researc...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business
Article
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced the completion of its acquisition of the Purification & Filtration business of Solventum (NYSE: SOLV) for approximately $4.0 billion in cash. With the transaction complete, the business, which is now Thermo Fisher’s Filtration and...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US7140461093
Revvity Inc
RVTY
LISTED
NYSE
Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina
Article
News Preview
Revvity, Inc. (NYSE: RVTY), today announced the opening of its new In Vivo Imaging Center of Excellence in Morrisville, North Carolina, the heart of the state’s Research Triangle. The center consolidates Revvity’s expertise and resources to drive R&D innovation and create the next generation of imaging systems backed by AI software tools and o...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US68218J1034
OmniAb Inc
OABI
LISTED
NASDAQ
OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
Article
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced that management will participate at the H.C. Wainwright 27th Annual Global Investment Conference taking place September 8-10, 2025 at the Lotte New York Palace Hotel. Management will be available for one-on-one meetings on Tuesday, September 9th with investors registered for the event. Investors intere...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: US53566P1093
Lineage Cell Therapeutics Inc.
LCTX
LISTED
TLV
Lineage Cell Therapeutics to Present at September 2025 Investor Conferences
Article
News Preview
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious neurological and ophthalmic conditions, today announced that Brian M. Culley, Lineage’s Chief Executive Officer, will be presenting at the H.C. Wainwright 27th Annual Glo...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
ISIN: GB00B9GTXM62
Silence Therapeutics PLC
SLNCF
LISTED
OTC
Silence Therapeutics to Participate in September Investor Conferences
Article
News Preview
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in the following conferences: Morgan Stanley Global Healthcare Conference Fireside Chat on Tuesday, September 9, 2025 at 5:35 p.m. ET H...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
Article
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04NET ASSET VALUEThe estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 1 September 2025 was 356.39p (cum income).                                ...
Themefolio
Profiler
Peergroup
© PR Newswire
02.09.2025
ISIN: US45828J1034
Intensity Therapeutics, Inc.
INTS
LISTED
NASDAQ
Intensity Therapeutics, Inc. to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
Article
News Preview
SHELTON, Conn., Sept. 2, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to kill tumors and increase immune system recognition of cancers using its proprieta...
Themefolio
Profiler
Peergroup
© Newsfile
02.09.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies Provides OST-HER2 Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma Program Update Following FDA End of Phase 2 Meeting
Article
News Preview
Company on track to begin submission of a rolling Biologics Licensing Application (BLA) request for OST-HER2 to U.S. Food & Drug Administration in September 2025 New York, New York--(Newsfile Corp. - September 2, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Tuesday, 18.11.2025, Calendar Week 47, 322nd day of the year, 43 days remaining until EoY.